Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

A QA program for MRD testing demonstrates that systematic education can reduce discordance among experienced interpreters.

Keeney M, Wood BL, Hedley BD, DiGiuseppe JA, Stetler-Stevenson M, Paietta E, Lozanski G, Seegmiller AC, Greig BW, Shaver AC, Mukundan L, Higley HR, Sigman CC, Kelloff G, Jessup JM, Borowitz MJ.

Cytometry B Clin Cytom. 2017 May 5. doi: 10.1002/cyto.b.21528. [Epub ahead of print]

PMID:
28475275
2.

The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications.

Anderson KC, Auclair D, Kelloff GJ, Sigman CC, Avet-Loiseau H, Farrell AT, Gormley NJ, Kumar SK, Landgren O, Munshi NC, Cavo M, Davies FE, Di Bacco A, Dickey JS, Gutman SI, Higley HR, Hussein MA, Jessup JM, Kirsch IR, Little RF, Loberg RD, Lohr JG, Mukundan L, Omel JL, Pugh TJ, Reaman GH, Robbins MD, Sasser AK, Valente N, Zamagni E.

Clin Cancer Res. 2017 Aug 1;23(15):3980-3993. doi: 10.1158/1078-0432.CCR-16-2895. Epub 2017 Apr 20.

PMID:
28428191
3.

Challenges in clinical prostate cancer: role of imaging.

Kelloff GJ, Choyke P, Coffey DS; Prostate Cancer Imaging Working Group.

AJR Am J Roentgenol. 2009 Jun;192(6):1455-70. doi: 10.2214/AJR.09.2579.

4.

Workshop on imaging science development for cancer prevention and preemption.

Kelloff GJ, Sullivan DC, Baker H, Clarke LP, Nordstrom R, Tatum JL, Dorfman GS, Jacobs P, Berg CD, Pomper MG, Birrer MJ, Tempero M, Higley HR, Petty BG, Sigman CC, Maley C, Sharma P, Wax A, Ginsberg GG, Dannenberg AJ, Hawk ET, Messing EM, Grossman HB, Harisinghani M, Bigio IJ, Griebel D, Henson DE, Fabian CJ, Ferrara K, Fantini S, Schnall MD, Zujewski JA, Hayes W, Klein EA, DeMarzo A, Ocak I, Ketterling JA, Tempany C, Shtern F, Parnes HL, Gomez J, Srivastava S, Szabo E, Lam S, Seibel EJ, Massion P, McLennan G, Cleary K, Suh R, Burt RW, Pfeiffer RM, Hoffman JM, Roy HK, Wang T, Limburg PJ, El-Deiry WS, Papadimitrakopoulou V, Hittelman WN, MacAulay C, Veltri RW, Solomon D, Jeronimo J, Richards-Kortum R, Johnson KA, Viner JL, Stratton SP, Rajadhyaksha M, Dhawan A; Workshop Program Committee.

Cancer Biomark. 2007;3(1):1-33.

PMID:
17655039
5.

FDG-PET lymphoma demonstration project invitational workshop.

Kelloff GJ, Sullivan DM, Wilson W, Cheson B, Juweid M, Mills GQ, Zelenetz AD, Horning SJ, Weber W, Sargent DJ, Dodd L, Korn E, Armitage J, Schilsky R, Christian M, O'connor OA, Wang SJ, Farrell AT, Pazdur R, Graham M, Wahl RL, Larson SM, Kostakoglu L, Daube-Witherspoon M, Gastonis C, Siegel BA, Shankar LK, Lee DB, Higley HR, Sigman CC, Carucci D, Timko D, deGennaro LJ, Sigal E, Barker A, Woodcock J.

Acad Radiol. 2007 Mar;14(3):330-9.

PMID:
17307666
6.

Chemoprevention strategies in the prostate: an overview.

Kelloff GJ, Higley HR, Brawer MK, Lucia MS, Sigman CC, Crawford ED.

Rev Urol. 2002 Spring;4(2):69-77.

7.

Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer.

Kelloff GJ, Lieberman R, Steele VE, Boone CW, Lubet RA, Kopelovich L, Malone WA, Crowell JA, Higley HR, Sigman CC.

Urology. 2001 Apr;57(4 Suppl 1):46-51.

PMID:
11295594
8.

Regulatory activity of endogenous and exogenous transforming growth factor beta in experimental intestinal immunopathology.

Mowat AM, Garside P, Fitton LA, Higley HR, Carlino JA.

Growth Factors. 1996;13(1-2):75-85.

PMID:
8962722
9.

Extravasation of macromolecules and possible trapping of transforming growth factor-beta in venous ulceration.

Higley HR, Ksander GA, Gerhardt CO, Falanga V.

Br J Dermatol. 1995 Jan;132(1):79-85.

PMID:
7538779
10.

Growth acceleration and stem cell expansion in Dexter-type cultures by neutralization of TGF-beta.

Waegell WO, Higley HR, Kincade PW, Dasch JR.

Exp Hematol. 1994 Oct;22(11):1051-7.

PMID:
7925771
11.

Transforming growth factor beta 1 systemically modulates granuloid, erythroid, lymphoid, and thrombocytic cells in mice.

Carlino JA, Higley HR, Creson JR, Avis PD, Ogawa Y, Ellingsworth LR.

Exp Hematol. 1992 Sep;20(8):943-50.

PMID:
1505639
12.

Abscess formation and local necrosis after treatment with Zyderm or Zyplast collagen implant.

Hanke CW, Higley HR, Jolivette DM, Swanson NA, Stegman SJ.

J Am Acad Dermatol. 1991 Aug;25(2 Pt 1):319-26. Review.

PMID:
1918471
13.

Developmental expression of adenosine deaminase in the upper alimentary tract of mice.

Chinsky JM, Ramamurthy V, Fanslow WC, Ingolia DE, Blackburn MR, Shaffer KT, Higley HR, Trentin JJ, Rudolph FB, Knudsen TB, et al.

Differentiation. 1990 Feb;42(3):172-83.

PMID:
2187728
14.

Developmental expression of adenosine deaminase in placental tissues of the early postimplantation mouse embryo and uterine stroma.

Knudsen TB, Green JD, Airhart MJ, Higley HR, Chinsky JM, Kellems RE.

Biol Reprod. 1988 Nov;39(4):937-51.

PMID:
3061489
15.

Glial fibrillary acidic protein and S-100 protein in pineal supportive cells: an electron microscopic study.

Higley HR, McNulty JA, Rowden G.

Brain Res. 1984 Jun 18;304(1):117-20.

PMID:
6378321
16.

Morphometric analysis of thymic medullary non-lymphoid cell changes during postnatal development.

Higley HR, O'Morchoe CC.

Dev Comp Immunol. 1984 Summer;8(3):711-9.

PMID:
6500140
17.

Supplemental Content

Loading ...
Support Center